Completed Access to Information Requests

Transitional Period

Federal departments are moving their web content to Canada.ca. As a part of that process, proactive disclosure reports will become available through the Open Government portal.  During this transition, if a proactive disclosure report from a specific department is not yet available on the Open Government portal please refer to Proactive disclosure by department or agency where a copy can be found.  For any questions on this issue, please contact us at open-ouvert@tbs-sct.gc.ca .

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests previously made to the Government of Canada. If you find a summary of interest, you can request a copy of the records at no cost. For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator.

Enter keywords (e.g. institution, topic, field of interest, etc.)
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Found 504 record(s)

Req # A-2015-000315

Adverse Reaction Report (AER) for Alfuzosin Hydrochloride. Report numbers: E2B_0334048, E2B_00319740, 000654310, E2B_00390907.

Organization: Health Canada

50 page(s)
December 2017

Req # A-2016-001732

Adverse Reaction Report (AER) for Metformin. Report numbers: E2B_00455554, E2B_00456004.

Organization: Health Canada

13 page(s)
December 2017

Req # A-2017-000803

Adverse Reaction Report (AER) for metronidazole. Report numbers: 000683724, E2B_00894897, E2B_00989979.

Organization: Health Canada

56 page(s)
December 2017

Req # A-2016-000723

All records including third-party submissions regarding departmental consultations on irradiation of ground beef from April 1, 2015 to September 8, 2016.

Organization: Health Canada

154 page(s)
December 2017

Req # A-2012-000046

All documents on developing a new tobacco control strategy, 2012 - 2013 gaps in existing tobacco control, new approaches to lowering the smoker number and evaluation reports on tobacco control programs.

Organization: Health Canada

299 page(s)
December 2017

Req # A-2016-000869

Adverse Reaction Report (AER) for zopiclone. Report numbers: E2B_00182318, E2B_00180451, E2B_00181255, E2B_00197100, 000638438.

Organization: Health Canada

309 page(s)
December 2017

Req # A-2013-000023

All records pertaining to the application by Multidisciplinary Association for Psychedelic Studies (MAPS) asking Health Canada for permission to use methylenedioxymethamphetamine (MDMA) as a medicine for Post Traumatic Stress Disorder (PTSD).

Organization: Health Canada

829 page(s)
December 2017

Req # A-2014-000145

Copy of pharmaco-vigilance practices inspection report since August 1, 2004 in which a Market Authorization Holder or importer received a non-compliant rating.

Organization: Health Canada

66 page(s)
December 2017

Req # A-2014-000158

Reviewers notes for clinical section for Non-Extended Days Supply (NDS) for ANDROGEL (ABBOTT LABORATORIES, LIMITED).

Organization: Health Canada

70 page(s)
December 2017

Req # A-2014-000226

All documents in the Administrative New Drug Submission approved January 28, 2014 between the sponsor and Health Canada for NOVO-5-ASA (5-aminosalicylic Acid 400 mg Enteric Coated Tablets, Drug Identification Number (DIN) 02171929.

Organization: Health Canada

46 page(s)
December 2017